Sampling correction in drug release testing is a material-balance adjustment for the substance removed, added or diluted when a receiver is sampled repeatedly. A measured concentration describes material still present at that moment; cumulative release also includes material withdrawn earlier. The distinction belongs to interpretation of an in vitro drug release test, whose transport and separation conditions are part of the measured system.[ref]
Let and be receiver volume and concentration just before the th withdrawal. At earlier observations , remove volume at concentration and add volume containing concentration . With initial receiver amount , conservation gives the cumulative amount contributed by the formulation:
The terms account for material remaining, material already removed and material supplied from elsewhere. The equation assumes that measured species is conserved and that the receiver is well mixed; adsorption or chemical transformation requires additional terms.
For initially blank medium, blank replacement and constant volume , this reduces to . If the aliquots are not replaced, the current volume instead satisfies .
Consider an illustrative receiver initially containing . Withdraw at without replacement. At the next observation, and , so the cumulative amount is . Incorrectly retaining the initial volume in the calculation would give . These chosen numbers illustrate accounting, not a formulation specification.
The sampling schedule and replacement protocol must therefore accompany a release curve. A decline in concentration after dilution does not imply that previously released material returned to the carrier. Similarly, a finite-difference drug release rate should be calculated from corrected cumulative amounts, with uncertainty and any shared measurement errors carried through the calculation.

Articles by others on the same topic (0)

There are currently no matching articles.